Cargando…
Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia
Resistance to regulated cell death is one of the hallmarks of human cancers; it maintains cell survival and significantly limits the effectiveness of conventional drug therapy. Leukemia represents a class of hematologic malignancies that is characterized by dysregulation of cell death pathways and t...
Autores principales: | Huang, Xianbo, Xiao, Feng, Li, Yuan, Qian, Wenbin, Ding, Wei, Ye, Xiujin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291981/ https://www.ncbi.nlm.nih.gov/pubmed/30541583 http://dx.doi.org/10.1186/s13046-018-0976-z |
Ejemplares similares
-
Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p/MLKL axis in chronic myeloid leukemia
por: Huang, Xianbo, et al.
Publicado: (2020) -
Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives
por: Huang, Xianbo, et al.
Publicado: (2020) -
Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2019) -
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
por: Nicolai, S, et al.
Publicado: (2015) -
The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy
por: Huang, Xianbo, et al.
Publicado: (2019)